Abstract
Background: CuII(atsm) [(diacetylbis(N(4)-methylthiosemicarbazonato) copper(II)] was orally administrated to transgenic
SOD1G93A mice.
Results: Treatment significantly prolonged lifespan with preservation of motor neurons. Reduced protein oxidation, attenuated
astrocyte, and microglial activation also resulted from treatment.
Conclusion: CuII(atsm) is neuroprotective in this model even when treatment begins after the onset of disease symptoms.
Significance: The drug has therapeutic potential for amyotrophic lateral sclerosis.
| Original language | English |
|---|---|
| Pages (from-to) | 44035 - 44044 |
| Number of pages | 10 |
| Journal | Journal of Biological Chemistry |
| Volume | 286 |
| Issue number | 51 |
| DOIs | |
| Publication status | Published - 2011 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver